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Constitutional Mutations in RTEL1
Cause Severe Dyskeratosis Congenita
Amanda J. Walne,1,3,* Tom Vulliamy,1,3 Michael Kirwan,1 Vincent Plagnol,2 and Inderjeet Dokal1
Dyskeratosis congenita (DC) and its phenotypically severe variant, Hoyeraal-Hreidarsson syndrome (HHS), are multisystem bone-
marrow-failure syndromes in which the principal pathology is defective telomere maintenance. The genetic basis of many cases of
DC and HHS remains unknown. Using whole-exome sequencing, we identified biallelic mutations in RTEL1, encoding a helicase essen-
tial for telomeremaintenance and regulation of homologous recombination, in an individual with familial HHS. Additional screening of
RTEL1 identified biallelic mutations in 6/23 index cases with HHS but none in 102 DC or DC-like cases. All 11 mutations in ten HHS
individuals from seven families segregated in an autosomal-recessive manner, and telomere lengths were significantly shorter in cases
than in controls (p ¼ 0.0003). This group had significantly higher levels of telomeric circles, produced as a consequence of incorrect
processing of telomere ends, than did controls (p ¼ 0.0148). These biallelic RTEL1 mutations are responsible for a major subgroup
(~29%) of HHS. Our studies show that cells harboring these mutations have significant defects in telomere maintenance, but not in
homologous recombination, and that incorrect resolution of T-loops is a mechanism for telomere shortening and disease causation
in humans. They also demonstrate the severe multisystem consequences of its dysfunction.Dyskeratosis congenita (DC [MIM 305000]) is a complex
bone-marrow (BM)-failure syndrome in which the prin-
cipal pathology is defective telomere maintenance and is
associated with short telomeres.1–3 Eight of the genes
known to be mutated in DC are involved in telomere
maintenance and account for the genetic basis of approx-
imately 60% of DC cases.3–6 The classical presentation of
DC includes abnormal skin pigmentation, nail dystrophy,
and oral leukoplakia. Individuals with DC frequently
develop BM failure and are at a high risk of developing
cancer, as well as a variety of other features.7 Hoyeraal-
Hreidarsson syndrome (HHS [MIM 300240]) is a phenotyp-
ically severe DC variant that is characterized by a variety of
features, including BM failure, intrauterine growth restric-
tion, developmental delay, cerebellar hypoplasia, immu-
nodeficiency,8 and usually short telomeres. Although the
genetic basis of some cases of HHS has been elucidated,
in many cases it remains unknown.
We recruited individuals who were classified as having
DC on the basis of previously published clinical criteria7
to the Dyskeratosis Congenita Registry (DCR) in London.
They were also included if they had at least four of six of
the most commonly recognized HHS-associated features
(intrauterine growth restriction, developmental delay,
microcephaly, cerebellar hypoplasia, immunodeficiency,
and BM failure). All samples were obtained with informed
consent and the approval of our local ethics committee.
We performed whole-exome sequencing on an indi-
vidual with genetically uncharacterized familial HHS by
using the TruSeq Exome enrichment kit (Illumina, UK).
The Illumina HighSeq 2000 systemwas used for generating
100 bp paired-end reads. Sequencing data were processed
through the Illumina pipeline, and rare and very rare vari-1Centre for Paediatrics, Barts and The London School of Medicine and Denti
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in dbSNP and the 1000 Genomes Project. It was hoped that
selecting an individual with a severe phenotype would
enrichagroupof clinicallymatched index caseswithhighly
penetrant disease-causing mutations. Under the assump-
tion of an autosomal-recessive mode of inheritance, seven
genes remained as possible candidates (Table S1, available
online). On the basis of function, RTEL1 (regulator of telo-
mere length 1 [MIM 608833]) warranted further investiga-
tion. RTEL1 is an essential helicase that is crucial for telo-
mere maintenance and DNA repair. In mice, it has been
shown to play a critical role in genome stability because
its knockout causes embryonic death, telomere loss, and
chromosome fusions.9 RTEL1 has also been implicated as
an antirecombinase in that it disrupts D-loop formation
during homologous recombination10 and is essential for
the disassembly of T-loops during DNA replication.11
Sanger sequencing of RTEL1 (RefSeq accession number
NM_032957.4) in the index case, her unaffected sibling,
and her parents confirmed the presence and segregation
of mutations c.2288G>T (p.Gly763Val) and c.3791G>A
(p.Arg1264His) (this latter mutation is based on the alter-
native splice variant uc021wge.1 from the UCSC Genome
Browser; DCR family 129 in Table 1 and Figure 1A) with
disease. This suggests that these mutations could be causal
in this family.
To determine whether RTEL1mutations are a significant
cause of HHS, we extended the screen of RTEL1 to a larger
group of individuals. On the basis of the clinical definition
of HHS and the presentation of the initial family, we
selected 23 additional index cases with global BM failure
and cerebellar hypoplasia from our DCR (Table S2). We
scanned for mutations by denaturing high-performancestry, Queen Mary University of London, Barts and The London Children’s
Gower Street, London WC1E 6BT, UK
y of Human Genetics.
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Table 1. Common Features of Individuals with Biallelic RTEL1 Mutations
Families from the Dyskeratosis Congenita Registry
129 093 103a 237 302 303 333
II-1 II-3 II-1 II-3 II-2 II-3 II-4 II-5 II-1 II-3 II-2 II-1
Mutation(s) NA c.2288G>T
(p.Gly763Val)
c.2964T>G (p.Phe988Leu)
(homozygous)
c.1548G>T (p.Met516Ile) NA c.102þ2T>C
(splice site)c
c.2201T>G
(p.Leu734Arg)
c.1263þ3A>G
(p.del422_446)
c.823G>A
(p.Glu275Lys)
c.3791G>A
(p.Arg1264His)b
c.2992C>T (p.Arg998Ter) c.2941C>T
(p.Arg981Trp)
c.2761A>G
(p.Lys921Glu)
c.2941C>T
(p.Arg981Trp)
c.2941C>T
(p.Arg981Trp)
Gender male female female male female male female male female female male male
Age at report or (death)
in years
(3) 8 16 (9) 16 (4) (11) (4) (4) 2 12 6
Global bone-marrow failure þ þ þ þ þ þ þ þ þ þ þ þ
Immunodeficiency þ þ  unknown þ þ þ þ þ þ þ/ 
Cerebellar hypoplasia þ   þ þ þ þ þ þ þ þ þ
Microcephaly þ   þ þ þ þ þ þ þ þ 
IUGR þ   þ þ þ þ þ þ þ þ 
Growth retardation þ   þ  þ þ þ þ þ þ þ
Developmental delay þ   þ  þ þ þ  þ þ þ
Abnormal skin pigmentation            
Nail dystrophy   þ/  þ  þ   þ þ 
Leukoplakia   þ  þ/  þ   þ  þ
Other features    hypogonadism      esophageal web
and enteropathy
dysphagia abnormal facies
and intracranial
calcification
Increased chromosomal
breakage with DEB
and/or MMC
  unknown        unknown 
The following abbreviations are used: IUGR, intrauterine growth restriction; DEB, diepoxybutane; MMC, mitomycin C; þ, present feature; –, absent feature; þ/, some suggestion that feature is present; and NA, sample not
available for analysis.
aFamily previously published.12
bMutation and predicted protein change were called from the alternative splice variant uc021wge.1.
cPredicted to affect splicing.
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Figure 1. Segregation of RTEL1 Mutations in HHS-Affected Families and the Location of RTEL1 Alterations in the Different Protein
Domains
(A) Segregation of RTEL1 mutations causing HHS. Shown are seven families in which RTEL1 mutations segregate as an autosomal-
recessive trait. Where available, the genotype of each individual is shown as a plus sign for the wild-type allele and as a minus sign
for the mutated allele. The asterisk indicates that the mutation appears to have arisen de novo.
(B) Conservation of altered RTEL1 amino acids. Blocks of amino acid alignment were generated with ClustalW and show the degree of
conservation of the altered amino acid residues in RTEL1. Sequences are as follows: human, H. sapiens (RTEL1 [RefSeq NP_116575.3]);
mouse, M. musculus (RTEL1 [RefSeq NP_001001882.3]); chicken, G. gallus (RTEL1 [RefSeq XP_417435.3]); and fruit fly, D. melanogaster
(RTEL1 [RefSeq NP_572254.1]). Asterisks indicate positions that have a single fully conserved residue, colons indicate conservation
between groups of strongly similar properties, and periods indicate conservation between groups of weakly similar properties.
(C) Conserved functional domains predicted in the RTEL1 amino acid sequence show the relative positions of the alterations caused by
the mutations observed in our subject group. Domains are as follows: I–VI, helicase domains; PIP, proliferating cell nuclear antigen
(PCNA)-interacting protein domain; green bar, iron-sulfur domain; purple bar, DEXDc2-DEAD-like helicase superfamily domain; brown
bar, DEAH box; orange bar, helicase C-terminal domain; and blue bar, helicase, superfamily 1 and 2, ATP-binding domain, DinG/Rad3-
type. The hatched C terminus is from isoform uc021wge.1.liquid chromatography on a Transgenomic Wave DNA-
fragment analysis system (Transgenomic, Glasgow, UK).
Any fragments showing abnormal elution patterns were
reamplified, and variants were confirmed by Sanger
sequencing. We considered nonsynonymous, splice-site,
or loss-of-function variants absent from the 1000Genomes
Project as potentially disease-causing mutations.
Biallelic RTEL1 mutations were observed in a further six
index cases, all of whom had a similar clinical phenotype,
resulting in the identification of one homozygous and
eight heterozygous mutations, of which six were missense,
two affected the donor splice site, and one was a stop-gain
mutation (Table 1, Figures 1B and 1C, and Table S3). The
missense mutations identified occurred at residues that
are generally highly conserved, and five of them aligned
across mouse, chicken, and fruit fly proteins (Figure 1B).
c.2941C>T (p.Arg981Trp) was recurrent—it was seen in
three families (DCR families 237, 303, and 333). In total,
11 different RTEL1 mutations were identified in ten cases
from seven families, and all of them segregated with
disease as an autosomal-recessive trait (Figure 1A).
To determine whether any of these variations had been
described previously, we consulted the publically available450 The American Journal of Human Genetics 92, 448–453, March 7data on the NHLBI Exome Sequencing Project Exome
Variant Server (EVS). Of the mutations reported in this
study, only one (c.1548G>T, reported at a frequency of
1/12,937 on the NHLBI EVS, accessed December 2012)
had been reported on this website in over 12,000 exomes
sequenced. We also had access to the exome data from
an additional 60 individuals, and none of the variations
reported here were seen in this group. Using the same
filtering criteria (absent in the 1000 Genomes data set),
we found the combined frequency of rare RTEL1 nonsy-
nonymous, loss-of-function, and splice variants in the
NHLBI data set to be between 2.3% in European Americans
and 3.4% in African Americans. Hence, the expected
frequency of individuals carrying biallelic RTEL1 variants
was much lower in the control population (approximately
1/1,000) than in our disease group (6/23, chi-square
p < 1010). On the basis of this, we suggest that these
mutations are causal for disease in a subset of individuals
with HHS.
The biallelic mutations we identified are associated with
a subset of HHS individuals with a tightly overlapping
phenotype (Table 1). The key common features are
global BM failure and cerebellar hypoplasia, and a large, 2013
Figure 2. Functional Effects of RTEL1
Mutations in Individuals with HHS
(A) Telomere lengths measured by mono-
chrome multiplex quantitative PCR are
expressed as a telomere-to-single-copy-
gene (T/S) ratio (individuals with biallelic
RTEL1 mutations are compared to con-
trols). Red squares represent cases, and
gray circles represent controls.
(B) Mutations in RTEL1 affect T-circle
accumulation. Linear terminal restriction
fragments (TRFs) and Phi-29-dependant
T-circles (TCs) were detected in genomic
DNA by Southern blot analysis.
(C) Graphical representation of the
increase in the production of T-circles in cases (P1 and P2) and controls (C1–C3). A box plot of the median value from
three different experiments shows the interquartile range (p ¼ 0.0148, unpaired t test).proportion also have microcephaly, intrauterine and extra-
uterine growth restriction, and immunodeficiency mainly
affecting the B cell lineage. It is noteworthy that none of
these individuals present with abnormal skin pigmenta-
tion, and less than half (~41%) have any indications of
nail dystrophy or leukoplakia. In contrast, the incidences
of these three features in classical DC are approximately
89% (for abnormal skin pigmentation), 88% (for nail
dystrophy), and 78% (for leukoplakia).3
Interestingly, c.1263þ3A>G observed in DCR family
303 is a de novo mutation in this family’s index case. Bidi-
rectional sequencing of both parents failed to identify this
mutation. To examine the effect of this mutation, we ex-
tracted RNA from whole blood with a QIAGEN QIAamp
RNA Blood Kit and generated cDNA by using reverse tran-
scriptase (New England Biolabs, Hitchin, UK) and an oligo
dT primer. Sanger sequencing of exons 13–17 demon-
strated that c.1263þ3A>G results in the skipping of exon
15 and thus causes an in-frame deletion of 24 amino acids
(422–446, Figure S1).
To determine whether RTEL1 mutations are specific to
individuals with an HHS phenotype, we screened 102
index cases with DC or related BM-failure syndromes. No
biallelic mutations were found in this large group, suggest-
ing that biallelic RTEL1mutations are a relatively common
cause of HHS, defined by presentation with a minimum of
BM failure and cerebellar hypoplasia, but are not a major
cause of DC or related BM-failure syndromes.
Telomeres are complex nucleoprotein structures that
protect chromosome ends from cellular exonucleases and
nonhomologous-end joining and distinguish them from
double-stranded breaks, which can occur elsewhere in
the genome. This protection is achieved not only by the
involvement of proteins of the shelterin complex13 but
also by the creation of a lasso-like configuration called
a T-loop by the 30 end of telomeres.14 In this structure,
a 30 single-stranded overhang invades the double-stranded
telomeric region and displaces the identical strand of DNA
to form a displacement-loop (D-loop) at the base of the
T-loop. For DNA replication to occur, these loops need to
be resolved while maintaining telomere integrity. It is
also important that these telomeric-strand invasions areThe Amedistinguished from the preliminary step of a homologous
recombination event during double-strand break repair.13
Conditional mouse knockout studies have demonstrated
that RTEL1 is essential for telomere maintenance in terms
of both length and stability.10 To determine whether this
observation holds true in individuals with RTEL1 muta-
tions, we used quantitative PCR to measure telomere
length in samples for which we had DNA of sufficient
quality (n ¼ 5). A monochrome multiplex quantitative
PCR method adapted for use on a LightCycler 480 real-
time thermocycler (Roche, Little Chalfont, UK) was used
as described previously.15,16 The telomere lengths were
significantly shorter in the group with biallelic RTEL1
mutations than in controls (n ¼ 71) (p ¼ 0.0003, Mann-
Whitney U, Figure 2A).
In mice, RTEL1 is essential for survival—it is required
during telomere replication, in DNA-damage repair (specif-
ically in homologous recombination), and for efficient
elongation of the telomere by telomerase.17 Vannier et al.
demonstrated that RTEL1 is necessary to cause T-loop disas-
sembly and that T-loops only form with 30 single-stranded
DNA overhangs.11 It has been suggested that persistent
T-loops are inappropriately resolved by the SLX4 complex,
which cleaves the T-loop from the telomere. This results
in the formation of T-circles and a corresponding loss in
telomere length.13,17,18When RTEL1 is inactivated, T-circle
formation increases. To examine this potential mode of
telomere shortening in individuals with biallelic RTEL1
mutations, we utilized a T-circle amplification assay.19 The
formation of T-circles in genomic DNA from controls and
the index cases from DCR families 302 and 303 (for
whomtherewas good-quality genomicDNA)wasmeasured
(Figure 2B). Compared to the signal from the telomeric
terminal restriction fragment, the relative signal from the
T-circles was increased in the index cases (p ¼ 0.0148,
unpaired t test, Figure 2C), suggesting that these mutations
affect the ability of RTEL1 to correctly process T-loops and
thus result in telomere shortening and a relative increase
in T-circle formation. By contrast, there was no significant
difference in T-circle intensity between five HHS cases
with DKC1 (MIM 300126) mutations and the normal
controls (p ¼ 0.54, Mann Whitney U, Figure S2). Theserican Journal of Human Genetics 92, 448–453, March 7, 2013 451
data suggest that T-circle production is increased in individ-
uals with biallelic RTEL1 mutations, which is consistent
with observation in mice and supports a disease-causing
mechanism that results in the shortening of telomeres
without impacting the function of the telomerase complex.
The alterations caused by the mutations identified in
this study were spread throughout RTEL1 (Figure 1C),
and four were within the RAD3-related helicase domain.
Helicases are a group of proteins that function by using
ATP hydrolysis to catalyze the unwinding of polynucleic-
acid structures and are involved in DNA repair, replication,
recombination, chromosomal segregation, and telomere
maintenance.20 They can be classified into several families,
some of which are associated with human disease. One
such family is the RECQ helicase family; alterations in
WRN, BLM, and RECQL4 cause Werner syndrome (MIM
604611), Bloom syndrome (MIM 604610), and Roth-
mund-Thomson syndrome (MIM 603780),21 respectively.
The most recently identified helicase family with telomere
effects is the FANCJ family, which has several members,
including BRIP1 (FANCJ) and RTEL1. BRIP1 is associated
with Fanconi anemia (FA [MIM 227650]),22 a disorder char-
acterized by DNA repair and/or homologous recombina-
tion defects, and RTEL1 (shown in this study) is associated
with HHS. These diseases have some overlapping features,
but there are also clear differences. None of the RECQ-
associated diseases have global BM failure, but there is an
increased risk of cancers, whereas both FA and DC are char-
acterized by BM failure. Peripheral-blood lymphocytes
from several individuals with biallelic RTEL1 mutations
were tested for chromosomal breakage after exposure
to DNA cross-linking agents in the standard FA test
(Table 1), but unlike lymphocytes from individuals with
FA, they had no increased chromosomal breakage. This
demonstrates that lymphocytes with biallelic RTEL1muta-
tions do not exhibit the same cellular defects as lympho-
cytes from individuals with FA, suggesting that cells with
biallelic RTEL1 mutations do not have significant defects
in DNA repair and/or homologous recombination.
Two studies have previously suggested that HHS might
arise as a result of defects in telomere biology other than
just length. Touzot et al.23 showed that individuals with
HHS can have a variety of telomere defects. Critically short
telomeres are not inevitably associated with this severe
phenotype, and additional factors, some of which are
involved in telomere protection and/or replication, might
cause some cases of HHS. Lamm et al.12 presented findings
on a family reported here (DCR family 103) and noted
that leukocyte telomeres were severely short (as observed
in our study) but that fibroblast telomeres were of normal
length. They also found that the 30 single-stranded over-
hang was reduced in both cell types and that the cata-
lytic telomerase core functioned normally. Mutations
identified in RTEL1 might now explain some of their
observations.
In summary, we have identified biallelic RTEL1 muta-
tions responsible for a subgroup of HHS, a severe variant452 The American Journal of Human Genetics 92, 448–453, March 7of DC. We have also demonstrated that defective human
RTEL1 has a detrimental effect on telomere maintenance,
suggesting that incorrect resolution of T-loops is a mecha-
nism for telomere shortening in humans. Although
previous studies have suggested that RTEL1 is an essential
helicase for both telomere maintenance and the regulation
of homologous recombination, our study shows that cells
harboring biallelic RTEL1 mutations only have significant
defects in telomere maintenance. The identification of
mutations in RTEL1 extends the sphere of diseases that
can be classified as ‘‘telomereopathies’’ and adds to the
number of diseases that are caused by defective helicases.Supplemental Data
Supplemental Data include two figures and three tables and can be
found with this article online at http://www.cell.com/AJHG.Acknowledgments
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Note Added in Proof
While this manuscript was under review, Ballew et al. pub-
lished a paper entitled ‘‘Germline mutations of regulator of
telomere elongation helicase 1, RTEL1, in dyskeratosis con-
genita’’ (Hum. Genet., published online January 18, 2013).
This paper documents one family affected by biallelic
RTEL1 mutations causing HHS and two families affected
by heterozygous RTEL1 mutations (causing HHS in one
and causing DC in the other). Although the family afflicted
with biallelic RTEL1mutations is similar to the seven fami-
lies described in this study, the pathogenic role of the
heterozygous RTEL1 mutations in the other two families
is unclear.rican Journal of Human Genetics 92, 448–453, March 7, 2013 453
